A 48-year-old woman with T2D (A1c 8.2%) and CKD G2 is not at A1c goal on metformin and SGLT2 inhibitor. She has ASCVD. Best next agent?...

Question

A 48-year-old woman with T2D (A1c 8.2%) and CKD G2 is not at A1c goal on metformin and SGLT2 inhibitor. She has ASCVD. Best next agent?

Accepted Answer

GLP‑1 receptor agonist with proven CV benefit

Answer

Sulfonylurea

Answer

DPP‑4 inhibitor

Answer

Alpha-glucosidase inhibitor

Answer

Meglitinide

us-usmle-step-2 MCQ (SBA): Diabetes-GLP‑1 Add-on in ASCVD